Nano-X Imaging (NNOX) FCF Margin (2022 - 2026)
Nano-X Imaging (NNOX) posted quarterly FCF Margin of 282.46% for Q1 2026, up 6567.0% year-on-year from 4.24% in Q1 2025, and up 23.34% on a QoQ basis from 368.49% in Q4 2025.
Nano-X Imaging (NNOX) FCF Margin (2022 - 2026) Analysis & Trends
Nano-X Imaging (NNOX) has reported FCF Margin for 5 consecutive years, with 282.46% the latest figure, recorded in Q1 2026.
- Quarterly FCF Margin rose 6567.0% year-over-year to 282.46% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 297.18% (up 4809.0% YoY) and the FY2025 annual result came in at 313.06%, up 3582.0% from the prior year.
- FCF Margin rose to 282.46% in Q1 2026 per NNOX's latest filing, from 368.49% in the prior quarter.
- Over the last five years, FCF Margin for NNOX reached as high as 243.95% in Q3 2024 and fell as low as 1070.08% in Q4 2022.
- A 5-year average of 409.62% and a median of 368.49% in 2025 frame the typical range for FCF Margin.
- The largest YoY upside for FCF Margin was 29444 bps in 2023 against a maximum downside of 17796 bps in 2023.
- Year by year, FCF Margin stood at 1070.08% in 2022, then increased by 28 bps to 775.64% in 2023, then surged by 35 bps to 500.97% in 2024, then gained by 26 bps to 368.49% in 2025, then climbed by 23 bps to 282.46% in 2026.
- According to Business Quant data, FCF Margin over the past three periods registered 282.46%, 368.49%, and 261.13% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 8.20% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.89% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 21.26% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 3.29% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -1.28% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 37.67% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 6.68% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.18% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Nano-X Imaging | 67.53 Mn | 23.68 Mn | -2.59 Mn | -282.46% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -282.46% |
| Dec 31, 2025 | -368.49% |
| Sep 30, 2025 | -261.13% |
| Jun 30, 2025 | -271.68% |
| Mar 31, 2025 | -348.13% |
| Dec 31, 2024 | -500.97% |
| Sep 30, 2024 | -243.95% |
| Jun 30, 2024 | -282.99% |
| Mar 31, 2024 | -364.43% |
| Dec 31, 2023 | -775.64% |
| Sep 30, 2023 | -425.13% |
| Jun 30, 2023 | -378.39% |
| Mar 31, 2023 | -375.11% |
| Dec 31, 2022 | -1,070.08% |
| Sep 30, 2022 | -247.17% |
| Jun 30, 2022 | -372.95% |
| Mar 31, 2022 | -394.91% |